Shares of Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Free Report) crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.30 and traded as low as $0.26. Northwest Biotherapeutics shares last traded at $0.27, with a volume of 3,671,663 shares traded.
Northwest Biotherapeutics Stock Performance
The firm’s 50 day moving average price is $0.28 and its two-hundred day moving average price is $0.30. The company has a market cap of $361.38 million, a P/E ratio of -3.36 and a beta of -0.51.
Northwest Biotherapeutics (OTCMKTS:NWBO – Get Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The biotechnology company reported ($0.02) earnings per share for the quarter. The business had revenue of $0.36 million for the quarter.
About Northwest Biotherapeutics
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.
Featured Articles
- Five stocks we like better than Northwest Biotherapeutics
- What is a support level?
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- Using the MarketBeat Dividend Tax Calculator
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- What is Forex and How Does it Work?
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
